Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Revive Therapeutics Ltd (RVVTF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.02 0.00    0.00%
- Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 156,059
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 0.02 - 0.02
Revive Therapeutics 0.02 0.00 0.00%

RVVTF Balance Sheet

 
Featured here, the Balance Sheet for Revive Therapeutics Ltd, which summarizes the company's financial position including assets, liabilities and shareholder equity for each of the latest 4 period ending dates (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 0.991 1.89 2.35 2.96
Cash and Short Term Investments 0.708 1.59 2.09 2.66
Cash - - - -
Cash & Equivalents 0.708 1.59 2.09 2.66
Short Term Investments - - - -
Total Receivables, Net 0.138 0.14 0.157 0.186
Accounts Receivables - Trade, Net 0.086 0.119 0.138 0.131
Total Inventory - - - -
Prepaid Expenses 0.095 0.112 0.058 0.074
Other Current Assets, Total 0.05 0.05 0.05 0.05
Total Assets 12.88 13.78 14.25 15.77
Property/Plant/Equipment, Total - Net 0.001 0.001 0.001 0.002
Property/Plant/Equipment, Total - Gross 0.015 0.015 0.015 0.015
Accumulated Depreciation, Total -0.014 -0.014 -0.014 -0.013
Goodwill, Net - - - -
Intangibles, Net 11.72 11.72 11.72 12.5
Long Term Investments 0.162 0.162 0.162 0.25
Note Receivable - Long Term 0.052 0.02 0.019 0.054
Other Long Term Assets, Total - - - -
Other Assets, Total -0.088 -0.09 -0.094 -0.086
Total Current Liabilities 3.21 3.38 3.44 3.72
Accounts Payable 2.49 2.63 2.66 2.91
Payable/Accrued - - - -
Accrued Expenses 0.621 0.624 0.639 0.677
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 0.096 0.129 0.134 0.127
Other Current liabilities, Total - - - -
Total Liabilities 3.35 3.52 3.6 3.92
Total Long Term Debt 0.06 0.06 0.085 0.122
Long Term Debt 0.06 0.06 0.06 0.06
Capital Lease Obligations - - 0.025 0.062
Deferred Income Tax - - - -
Minority Interest - - - -
Other Liabilities, Total 0.018 0.02 0.018 0.02
Total Equity 9.53 10.26 10.65 11.85
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 46.02 45.98 45.98 45.98
Additional Paid-In Capital 12.66 12.66 12.66 12.41
Retained Earnings (Accumulated Deficit) -61.73 -60.96 -60.57 -59.38
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 12.58 12.58 12.58 12.83
Total Liabilities & Shareholders' Equity 12.88 13.78 14.25 15.77
Total Common Shares Outstanding 358.45 357.65 357.65 357.65
Total Preferred Shares Outstanding - - - -
* In Millions of CAD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RVV Comments

Write your thoughts about Revive Therapeutics Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Silver Surfer
Silver Surfer Mar 11, 2021 12:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy MindMed if your wants gains.
Maggie Cayetano
Maggie Cayetano Jan 25, 2021 11:09AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can’t wait to see it fly .
Alpesh Mistry
Alpesh Mistry Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i feel that going sky-high
Frank Rodriguez jr
Frank Rodriguez jr Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What are you basing your position on?
Connor Bovey
Connor Bovey Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Frank Rodriguez jr  Well they have phase 3 covid vaccine approved by FDA, and they just bought out a psylocibin company to start trials on addictions therapy using psychedelics. Which is already borderline proven to work. And there is a very obvious need for it given opioid crisis. Current day undervalued by min 675% based on predictive analysis and insured re-up market IDs
Connor Bovey
Connor Bovey Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Frank Rodriguez jr  Well RVV already has phase 3 covid vaccine FDA approved. They also bought up a psylocibin company to begin trials on using psychedelics for addiction treatment. Which works, and clearly a desperate necessity in todays opioid crisis. Undervalued by min 644% based on predictive analysis and market intel IDs
Connor Bovey
Connor Bovey Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
64.4-67.5%*
Alpesh Mistry
Alpesh Mistry Aug 29, 2020 9:25AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
i feel that going sky-high soon ?
christopher brown
christopher brown Aug 01, 2019 1:10PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This should explode soon.They have very good projects ramping up
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email